2.7 Science, Society, and Bioethics: Biotechnology, Health, and the Environment
Key Takeaways
- ETS Category I Subcategory B covers biotechnology (genetic engineering, GMOs), public-health applications (epidemics, vaccines, HIV/AIDS, pathogens), medical technologies (imaging, X-rays, radiation therapy), and ethical concerns (stem cells, cloning, genetic information).
- Bioethics rests on four principles: autonomy (informed consent), beneficence (do good), non-maleficence (do no harm), and justice (fair distribution of benefits and risks).
- GMOs raise testable benefit/risk trade-offs: higher yield and pest resistance versus gene flow, resistance evolution, and biodiversity/labeling concerns - the exam wants balanced evidence-based reasoning, not advocacy.
- Human impacts span air/water pollution, greenhouse gases and climate change, resource extraction, and habitat loss; sustainable management and conservation are the mitigation responses ETS lists.
- Many emerging infectious diseases are zoonotic and spread faster through crowding, travel, and habitat disruption; vaccines and epidemiology are the public-health countermeasures.
Why This Section Matters
Under Category I (Nature and Impact of Science and Engineering, 13% of test 5236), ETS lists a full subcategory B. Science, Engineering, Technology, Society, and the Environment. This is the Science, Technology and Social Perspectives (STS) content: biotechnology, public health, medical technology, bioethics, and environmental impacts. ETS expects you to reason about benefits and risks with evidence and to apply ethical principles to research and technology decisions - the kind of issues a teacher must handle when students ask about GMOs, vaccines, or cloning.
The Four Principles of Bioethics
Most ethics items can be solved with the standard biomedical-ethics framework:
| Principle | Meaning | Classroom/Research Application |
|---|---|---|
| Autonomy | Respect a person's right to decide. | Informed consent before any study or procedure. |
| Beneficence | Act for the subject's benefit. | Choose interventions expected to help. |
| Non-maleficence | "Do no harm." | Minimize risk; stop a trial that harms subjects. |
| Justice | Distribute benefits and burdens fairly. | Do not exploit vulnerable groups; share access. |
These trace to the Belmont Report (1979), written after abuses such as the Tuskegee syphilis study. Informed consent (autonomy) is the most frequently tested - the correct answer almost always protects the participant's right to understand and agree.
Biotechnology and GMOs
Genetic engineering inserts, edits, or silences specific genes. A genetically modified organism (GMO) carries DNA altered by these techniques (e.g., Bt corn expressing an insecticidal protein; golden rice engineered to make beta-carotene; bacteria engineered to make human insulin).
ETS wants balanced trade-off reasoning, not advocacy:
- Potential benefits: higher yields, pest and drought resistance, reduced pesticide use, nutritional enhancement, cheaper pharmaceuticals.
- Potential risks/concerns: gene flow to wild relatives, evolution of resistant pests/weeds, effects on non-target species and biodiversity, and socio-ethical issues (labeling, consent, equitable access, corporate seed control).
The correct exam answer evaluates evidence and acknowledges uncertainty rather than declaring GMOs simply "good" or "bad."
Ethical Use of Genetic Information and Cloning
- Genetic privacy: results can reveal disease risk and family information; laws (e.g., GINA in the U.S.) limit genetic discrimination in employment and insurance.
- Stem cells: embryonic stem cells are pluripotent but raise embryo-status concerns; induced pluripotent stem cells (iPSCs) sidestep that by reprogramming adult cells.
- Cloning: reproductive cloning (a whole organism, e.g., Dolly) is widely restricted in humans; therapeutic cloning aims at tissues/cells, not a new individual.
Public Health, Disease, and Medicine
ETS lists epidemiology, epidemics/pandemics, HIV/AIDS, pathogens, and vaccines. Key exam points:
- Epidemiology studies disease distribution and determinants in populations (incidence, prevalence, transmission).
- Vaccines prime adaptive immunity, building memory cells; widespread coverage produces herd immunity that protects those who cannot be vaccinated.
- Emerging infectious diseases are increasing because many are zoonotic (cross from animals) and spread faster with global travel, urban crowding, refugee/temporary settlements, and habitat disruption that increases human-wildlife contact.
- Medical technologies for diagnosis and treatment include X-rays and medical imaging (MRI, CT, ultrasound) and radiation therapy for cancer.
Human Impacts on the Environment
This bridges to ecology (Category V) but is tested here as impacts of human activity:
- Air and water pollution from industry, agriculture (nutrient runoff -> eutrophication), and combustion.
- Greenhouse gases (CO2, CH4, N2O) drive global climate change, shifting ranges and phenology.
- Resource extraction, natural disasters, and industrial accidents degrade habitats; ocean, estuary, freshwater, and wetland degradation reduce ecosystem services.
- Responses ETS lists: conservation and species protection, habitat preservation/restoration, sustainable forestry/fisheries/agriculture, recycling, and renewable energy.
Common Praxis Traps
- Treating GMOs or vaccines as one-sided "good/bad" - the exam rewards evidence-based trade-off answers.
- Forgetting informed consent (autonomy) as the first ethical safeguard in a research scenario.
- Confusing reproductive vs. therapeutic cloning, or embryonic vs. induced pluripotent stem cells.
- Missing that emerging diseases spread faster due to crowding, travel, and habitat disruption, not just mutation.
Comparing Sources of Scientific Information
ETS's own discussion questions ask how to judge information from a newspaper, a website, television, and a peer-reviewed scientific journal. The ranking principle: a peer-reviewed journal article carries the most authority because experts vetted its methods and data before publication, while popular media may simplify, sensationalize, or omit uncertainty. As a teacher, you should model lateral reading - checking the source's expertise, funding, evidence, and whether claims are replicated. Distinguishing a primary research report from a secondary summary or an opinion piece is a tested information-literacy skill.
Applying the Framework to a Classroom Debate
When a stem describes a teacher running a debate on a socio-scientific issue (vaccination policy, GMO labeling, gene editing), the best move is rarely to declare a winner. ETS rewards having students gather evidence from credible sources, identify trade-offs, separate scientific facts from value judgments, and reason from data - the same evidence-and-ethics approach used in the four-principle framework above. Science can describe consequences and probabilities; deciding what we ought to do also involves values, so the strongest answer keeps the empirical and ethical dimensions distinct while informing each other.
Quick Reference: Mapping ETS Subcategory B Topics
Use this checklist to confirm you can address every item ETS lists under Subcategory B:
- Public health/medicine: epidemics and pandemics, HIV/AIDS, pathogens, vaccines, epidemiology.
- Biotechnology: genetic engineering, GMOs, recombinant products.
- Medical technology: medical imaging, X-rays, radiation therapy.
- Ethical research concerns: stem cells, toxic chemicals, animal/human subjects.
- Ethical use of technology: genetic information/privacy, organisms, cloning.
- Environmental impacts: air/water pollution, greenhouse gases and climate change, resource extraction, habitat and wetland degradation, conservation, sustainable resource use.
If a stem touches any of these, lead with evidence, name the trade-offs, and, for ethics, apply autonomy, beneficence, non-maleficence, and justice.
A biotech firm engineers a crop to resist a herbicide so farmers can spray weeds without harming the crop. A student asks whether this is good or bad. Which response BEST reflects the evidence-based reasoning ETS expects on bioethics items?
A researcher wants to enroll patients in a trial of a new cancer therapy. Before any treatment, she explains the risks, benefits, and alternatives and lets each patient decide whether to participate. Which bioethics principle does this MOST directly uphold?